Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Boku Narikazu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ito T; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan., Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sekine S; Department of Clinical Pathology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hashimoto T; Department of Clinical Pathology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Shimada Y; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Matsuda M; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Yamada M; Endoscopy Division, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hamamoto R; Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; RIKEN Center for Advanced Intelligence Project, Cancer Translational Research Team, Hirosawa, Wako, Saitama, 351-0198, Japan., Kato T; Department of Gynecology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Shida D; Department of Colorectal Surgery, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan., Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Takashima A; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. atakashi@ncc.go.jp., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kshirais@ncc.go.jp.
Publikováno v:
Scientific reports [Sci Rep] 2023 Mar 03; Vol. 13 (1), pp. 3587. Date of Electronic Publication: 2023 Mar 03.
Autor:
Komatsu M; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan. makomats@ncc.go.jp., Ichikawa H; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Chiwaki F; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan., Sakamoto H; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Komatsuzaki R; Division of Cancer Therapeutics, National Cancer Center Research Institute, Tokyo, Japan., Asaumi M; Advanced Informatics and Analytics, Astellas Pharma Inc, Ibaraki, Japan., Tsunoyama K; Advanced Informatics and Analytics, Astellas Pharma Inc, Ibaraki, Japan., Fukagawa T; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan., Matsushita H; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan., Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Matsusaki K; Ascites Treatment Center, Kanamecho Hospital, Tokyo, Japan., Takeshita F; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan., Yoshida T; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan., Sasaki H; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan. hksasaki@ncc.go.jp.
Publikováno v:
Oncogene [Oncogene] 2022 Oct; Vol. 41 (43), pp. 4779-4794. Date of Electronic Publication: 2022 Sep 20.
Autor:
Ooki A; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Satoh T; Palliative and Supportive Care Center, Osaka University Hospital, Osaka, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Takashima A; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Sakai D; Palliative and Supportive Care Center, Osaka University Hospital, Osaka, Japan., Ichimura T; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Mitani S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Kudo T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Chin K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Kitano S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Thai D; Gilead Sciences, Inc., Foster City, CA, USA., Zavodovskaya M; Gilead Sciences, Inc., Foster City, CA, USA., Liu J; Gilead Sciences, Inc., Foster City, CA, USA., Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yamaguchi K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. kensei.yamaguchi@jfcr.or.jp.
Publikováno v:
Scientific reports [Sci Rep] 2022 Jun 30; Vol. 12 (1), pp. 11007. Date of Electronic Publication: 2022 Jun 30.
Autor:
Hirano H; Laboratory of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan.; Department of Medicine, Keio University Graduate School of Medicine, Tokyo, 160-8582, Japan., Abe Y; Laboratory of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Division of Molecular Diagnostics, Aichi Cancer Center Research Institute, Nagoya, 464-8681, Japan., Nojima Y; Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Center for Mathematical Modeling and Data Science, Osaka University, Osaka, 560-8531, Japan., Aoki M; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan.; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, 606-8507, Japan., Shoji H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Isoyama J; Laboratory of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan., Honda K; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.; Department of Bioregulation, Nippon Medical School, Bunkyo-ku, Tokyo, 113-8602, Japan., Boku N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan.; Department of Medical Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, 108-8639, Japan., Mizuguchi K; Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.; Institute for Protein Research, Osaka University, Osaka, 565-0871, Japan., Tomonaga T; Laboratory of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan. tomonaga@nibiohn.go.jp.; Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan. tomonaga@nibiohn.go.jp., Adachi J; Laboratory of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan. jun_adachi@nibiohn.go.jp.; Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan. jun_adachi@nibiohn.go.jp.; Laboratory of Clinical and Analytical Chemistry, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan. jun_adachi@nibiohn.go.jp.
Publikováno v:
Scientific reports [Sci Rep] 2022 Mar 25; Vol. 12 (1), pp. 4419. Date of Electronic Publication: 2022 Mar 25.
Autor:
Tanaka Y; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. yotanaka@ncc.go.jp., Chiwaki F; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan., Kojima S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Kawazu M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Komatsu M; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan., Ueno T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Inoue S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Sekine S; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Matsusaki K; Kanamecho Hospital, Tokyo, Japan., Matsushita H; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan., Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kanai Y; Department of Pathology, Keio University School of Medicine, Tokyo, Japan., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Sasaki H; Department of Translational Oncology, National Cancer Center Research Institute, Tokyo, Japan. hksasaki@ncc.go.jp., Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. hmano@ncc.go.jp.
Publikováno v:
Nature cancer [Nat Cancer] 2021 Sep; Vol. 2 (9), pp. 962-977. Date of Electronic Publication: 2021 Aug 16.